首页|巴瑞替尼联合疗法对类风湿性关节炎的效果及对内循环状态和骨代谢的影响

巴瑞替尼联合疗法对类风湿性关节炎的效果及对内循环状态和骨代谢的影响

扫码查看
目的 探讨巴瑞替尼联合疗法对类风湿性关节炎(rheumatoid arthritis,RA)的效果及对内循环状态和骨代谢的影响.方法 选择2021年1月至2023年12月于我院接受治疗的RA患者199例,以随机数表法分为观察组(n=100)和对照组(n=99).对照组予艾拉莫德联合甲氨蝶呤治疗,观察组在对照组治疗基础上加用巴瑞替尼,疗程均为90d.比较两组疗效、收缩期峰值速度(peak systolic velocity,PSV)、舒张期峰值速度(peak diastolic velocity,PDV)、血管阻力、血清骨钙素(osteocalcin,OC)、25-羟基维生素 D、β-胶原降解产物(collagen degradation product,CTX)、总 Ⅰ 型胶原氨基端延长肽(type Ⅰ collagen amino terminal lengthening peptide,PINP)、晨僵时间、关节触痛个数、关节肿胀个数、视觉模拟评分法(visual analogue scale,VAS)评分及不良反应发生情况.结果 治疗后,观察组总有效率高于对照组(91.00%vs 79.80%,P<0.05).两组PSV、PDV、OC、25-羟基维生素D、PINP水平较前升高,且观察组高于对照组(P<0.05);两组血管阻力、β-CTX、晨僵时间、关节触痛个数、关节肿胀个数、VAS评分较前降低或减少,且观察组低于对照组(P<0.05).两组不良反应总发生率无明显差异(P>0.05).结论 巴瑞替尼联合疗法对RA效果较佳,可一定程度改善患者内循环状态及骨代谢水平.
Effect of combination therapy with baritinib in the treatment of rheumatoid arthritis and influence of internal circulation status and bone metabolism
Objective To investigate the effect of combination therapy with baritinib in the treatment of rheumatoid arthritis(RA)and influence of internal circulation state and bone metabolism.Methods A total of 199 RA patients treated in our hospital from January 2021 to December 2023 were selected and divided into observation group(n=100)and control group(n=99)by random number table method.The control group was treated with eramod combined with methotrexate,and the observation group was treated with baritinib on the basis of the control group,the course of treatment was 90 days.The curative effect,peak systolic velocity(PSV),peak diastolic velocity(PDV),vascular resistance,serum osteocalcin(OC),25-hydroxyvitamin D,β-collagen degradation product(CTX),total type Ⅰ collagen amino terminal lengthening peptide(PINP),morning stiffness time,number of joint tenderness,number of joint swelling,visual analogue scale(VAS)score and incidence of adverse reactions were compared between the two groups.Results After treatment,the total effective rate of observation group was higher than that of control group(91.00%vs 79.80%,P<0.05).PSV,PDV,OC,25-hydroxyvitamin D and PINP in both groups were higher than before,and observation group was higher than control group(P<0.05).Vascular resistance,β-CTX,morning stiffness time,number of joint tenderness,number of joint swelling and VAS score in both groups were decreased,and the observation group was lower than the control group(P<0.05).There was no significant difference in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion Combination therapy with baritinib has a good effect in the adjuvant treatment of RA,and can improve the internal circulation status and bone metabolism level of patients to a certain extent.

baritinibrheumatoid arthritisinternal circulation statebone metabolism

金德恩、王小艳、李哲

展开 >

界首市人民医院内分泌科,安徽阜阳 236501

巴瑞替尼 类风湿性关节炎 内循环状态 骨代谢

2024

世界临床药物
上海医药工业研究院

世界临床药物

CSTPCD
影响因子:0.849
ISSN:1672-9188
年,卷(期):2024.45(9)
  • 14